At three outpatient diabetes clinics in Rome, Italy, participants who received specialized behavioral counseling sessions had greater increases in physical activity and decreases in sedentary time than those who received general physician recommendations.
The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.
The results of the CANVAS trial are promising for patients with type 2 diabetes mellitus (T2DM) and early chronic kidney disease, but ongoing research should provide more convincing data, said an ACP Journal Club commentary.
The pump can be used with various components of diabetes therapy systems, including automated insulin dosing systems, continuous glucose monitors, and blood glucose meters.